spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

CPhI Worldwide to support International Medical Corps UK with global charity partnership

CphI Worldwide 2017

Collaboration to help raise funds, awareness and engagement from pharma community for the charity’s lifesaving work in crises across the globe

Amsterdam, 4th October 2017: CPhI Worldwide, organised by UBM, announces a new dedicated charity partnership with International Medical Corps UK. The collaboration will see UBM extensively promote International Medical Corps across the global pharma community, with a range of fundraising and customised sponsorship packages.

International Medical Corps UK was selected in light of its vital work in delivering lifesaving healthcare and medicine on the frontlines of conflicts, natural disasters, famines and disease outbreaks. Spanning more than 25 countries, their work includes providing vital aid and supplies in hotspots such as Syria, South Sudan, Yemen and Afghanistan.

The charity specialises in delivering rapid support in crisis settings, often within just a few hours, and go where the needs are greatest. Donations will support worldwide relief, recovery and development projects such as midwifery training, emergency nutrition, clean water, improved sanitation and vaccination campaigns. They also enable International Medical Corps’ wider training efforts to equip local people with the knowledge and skills to be their own best First Responders.

UBM is supporting the charity by encouraging its enormous 100,000+ database to provide sponsorships via a variety of available charity packages and direct donations. Donations can be of any monetary value or in-kind while the charity packages range from €995 to €3995, with 100% of the sponsorship going directly to International Medical Corps.

To further incentivise the pharma industry, CPhI Worldwide will also provide a range of free advertising and promotion opportunities at the annual exhibition – the world’s largest pharma event – with a captive audience of more than 42,000 pharmaceutical professionals and industry press. CPhI will also facilitate pharma companies in the donation and distribution of vital medicines and vaccinations.

Rhylie Luanweir, Senior Group Marketing Manager at UBM EMEA commented: “This year we have partnered with International Medical Corps UK due to the outstanding work they carry out, from providing materials for sanitation and hygiene to emergency nutrition, on an international scale. More specifically, they provide their services in regions where people have very limited or no access to healthcare and medicine and in extremely challenging emergency situations. Their commitment and bravery is beyond reproach. CPhI Worldwide is a great platform to raise awareness of these communities in need, and motivate the pharma industry to incorporate charity giving into their business by simplifying the process. Businesses can extend their support in the form of purchasing packages, donating medicine or direct donations.”

“UBM’s long-standing commitment to the humanitarian sector makes them an ideal partner, and we’re thrilled to be working together. International Medical Corps have been given a fantastic opportunity to share our experiences with an industry integral to our work. The support of businesses, individuals and organisations like UBM is absolutely essential in order for us to continue to deliver life-saving care to the people who need it the most”
, added Kevin Noone, Executive Director, International Medical Corps UK.

To find how you or your business can help support this charity or to donate to International Medical Corps, please visit https://www.cphi.com/charity-and-sustainability.
email cphi@ubm.com
email Frankfurt, Germany
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Arquer Diagnostics Appoints Nadia Whittley as CEO


More info >>


White Papers

Running Better Trials Taking an Intelligent Monitoring Approach

Bioclinica

When it comes to implementing a risk-based monitoring program, it is not just about reducing monitoring visits and doing less Source Document Verification (SDV). It’s about bringing together your people, a solid process, and the right technology to run a better trial. Success with risk-based monitoring requires the ability to make sense of the thousands, if not millions, of data points captured by multiple disparate sources in a clinical trial. With the sheer volume of data generated on a daily basis comes complexity. How does one make sense of it all? Information overload burdens even the most experienced study teams who struggle to understand which data matters most and what it means.
More info >>

Industry Events

BIO-Europe® 2017

6-8 November 2017, Messedamm 26 14055 Berlin Germany

The 23rd annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 3,800 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. BIO-Europe's world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement